These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20650758)

  • 1. [Glitazones protects beta cell function from cytotoxic cytokines through PPAR gamma-dependent mechanisms].
    Li X; Wang AP; Yan X; Huang G; Liu BL; Zhou ZG
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1530-3. PubMed ID: 20650758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms.
    Wang AP; Li X; Zheng Y; Liu BL; Huang G; Yan X; Liu Z; Zhou Z
    Acta Diabetol; 2013 Apr; 50(2):163-73. PubMed ID: 21153483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effects of thiazolidinedione upon cytokine-induced apoptosis in pancreatic beta-cell line].
    Wang AP; Li X; Liu BL; Zheng Y; Zheng C; Lin J; Huang G; Yan X; Peng J; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1989-93. PubMed ID: 19950576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [1α, 25(OH)(2) D(3) protects pancreatic β-cell line from cytokine-induced apoptosis and impaired insulin secretion].
    Wang AP; Li X; Chao C; Huang G; Liu BL; Peng J; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):695-9. PubMed ID: 22781299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.
    Kono T; Ahn G; Moss DR; Gann L; Zarain-Herzberg A; Nishiki Y; Fueger PT; Ogihara T; Evans-Molina C
    Mol Endocrinol; 2012 Feb; 26(2):257-71. PubMed ID: 22240811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
    Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH
    Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
    Matsui J; Terauchi Y; Kubota N; Takamoto I; Eto K; Yamashita T; Komeda K; Yamauchi T; Kamon J; Kita S; Noda M; Kadowaki T
    Diabetes; 2004 Nov; 53(11):2844-54. PubMed ID: 15504964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells.
    Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK
    PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity.
    Shen X; Yang L; Yan S; Zheng H; Liang L; Cai X; Liao M
    Mol Cell Endocrinol; 2015 Sep; 412():1-11. PubMed ID: 25986658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice.
    Maganti AV; Tersey SA; Syed F; Nelson JB; Colvin SC; Maier B; Mirmira RG
    J Biol Chem; 2016 Oct; 291(43):22524-22533. PubMed ID: 27613867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
    Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
    Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and mechanism of rosiglitazone on the impairment of insulin secretion induced by free fatty acids on isolated rat islets.
    Tian JY; Li G; Gu YY; Zhang HL; Zhou WZ; Wang X; Zhu HD; Luo TH; Luo M
    Chin Med J (Engl); 2006 Apr; 119(7):574-80. PubMed ID: 16620699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
    Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
    Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.
    Emery MN; Leontiou C; Bonner SE; Merulli C; Nanzer AM; Musat M; Galloway M; Powell M; Nikookam K; Korbonits M; Grossman AB
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):389-95. PubMed ID: 16918962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.
    Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and long-term effects of peroxisome proliferator-activated receptor-γ activation on the function and insulin secretory responsiveness of clonal beta-cells.
    Irwin N; McKinney JM; Bailey CJ; McClenaghan NH; Flatt PR
    Horm Metab Res; 2011 Apr; 43(4):244-9. PubMed ID: 21165811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glitazones exert multiple effects on β-cell stimulus-secretion coupling.
    Düfer M; Noack K; Edalat A; Krippeit-Drews P; Drews G
    Mol Pharmacol; 2013 Jan; 83(1):51-60. PubMed ID: 23024191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets.
    Welters HJ; El Ouaamari A; Kawamori D; Meyer J; Hu J; Smith DM; Kulkarni RN
    Endocrinology; 2012 Oct; 153(10):4593-9. PubMed ID: 22807489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.